Cimzia 2X200 MG/ML syringe kits
Ended Awarded Last action
- Contract number
- SPE2DR26F0XL8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,023
Award facts
- Contract value 100% obligated
- $26,023.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $26,023.49 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of CIMZIA 2x200 mg/mL syringe kits, with an ultimate completion date of December 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. CIMZIA is a biologic immunosuppressant medication used to treat inflammatory conditions including rheumatoid arthritis, Crohn's disease, and psoriasis, making this procurement essential for supporting military and veteran healthcare needs.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime indefinite delivery vehicle (SPE2DX) functions as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through competitive procurement and its substantial pharmaceutical distribution network position it as a critical vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F0XL8?
SPE2DR26F0XL8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26F0XL8 worth?
The government has obligated $26,023 on SPE2DR26F0XL8.
Is contract SPE2DR26F0XL8 an order under another contract?
Yes. SPE2DR26F0XL8 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0XL8 competed?
The extent of competition for SPE2DR26F0XL8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award